Rephonic
Artwork for Prostate Cancer Update

Prostate Cancer Update

Dr. Neil Love
Prostate Cancer
Pembrolizumab
Immunotherapy
Renal Cell Carcinoma
Clinical Trials
Urethral Bladder Cancer
Urothelial Bladder Cancer
Hormonal Therapy
Androgen Receptor Pathway Inhibitors
PARP Inhibitors
Metastatic Urothelial Bladder Cancer
AKT Inhibitors
EMBARQ Study
Chemotherapy
Bladder Cancer
Antibody-Drug Conjugates
HER2
Tar-200
P10 Deficiency
Nivolumab

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.

PublishesWeeklyEpisodes178Founded20 years ago
Number of ListenersCategories
ScienceMedicineHealth & Fitness

Listen to this Podcast

Artwork for Prostate Cancer Update

Latest Episodes

Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer.

CME information and select publications here.

YouTube

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.

CME information and select publicati... more

YouTube

Dr Matthew Milowsky from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, comments on real patient cases of metastatic urothelial bladder cancer presented by Dr Jacqueline T Brown from the Emory University School of Medi... more

YouTube

Prof Karim Fizazi from the Centre Oscar Lambret in Lille, France, Dr Daniel George from the Duke Cancer Institute in Durham, North Carolina, and moderator Dr Elisabeth I Heath from Mayo Clinic in Rochester, Minnesota, discuss the future role of AKT i... more

YouTube

Dr Matthew Milowsky from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, comments on real patient cases of metastatic urothelial bladder cancer presented by Dr Jacqueline T Brown from the Emory University School of Medi... more

YouTube

Dr Matthew D Galsky from The Tisch Cancer Institute in New York, New York, Dr Shilpa Gupta from Cleveland Clinic’s Taussig Cancer Institute in Ohio, Prof Andrea Necchi from IRCCS San Raffaele Hospital in Milan, Italy, and moderator Dr Terence Friedla... more

YouTube

Dr Terence Friedlander discusses the selection and sequencing of therapy for patients with bladder cancer and reviews clinical findings recently presented at the 2025 ESMO Congress.

CME information and select publications here.

Dr Fern Anari from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Catherine Fahey from the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, present real patient cases on metastatic bladder cancer, with additio... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Matt Milowsky
Oncologist discussing metastatic urothelial bladder cancer cases
University of North Carolina, Lindbergh Comprehensive Cancer Center
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 4
Nazli Dizman
Urologic medical oncologist presenting cases
University of Texas MD Anderson Cancer Center
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 4
Jacqueline Brown
Oncologist presenting cases
Emory University School of Medicine
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 4
Niraj Agarwal
Interview participant referenced in video interviews
University of Utah, Huntsman Cancer Center
Episode: AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Raina McKay
Interview participant referenced in video interviews
Moores Cancer Center, UC San Diego
Episode: AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Matthew Galsky
Oncologist, Mount Sinai
Mount Sinai
Episode: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Andrea Necchi
Medical oncologist, Milano
Milano
Episode: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Shilpa Gupta
Cleveland Clinic
Cleveland Clinic
Episode: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Betsy Plymick
Medical oncologist
Episode: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

Host

Dr. Neil Love
Medical oncologist and host with long-running roles in oncology education and updates.

Top Science Podcasts

Something You Should Know
Something You Should KnowMike Carruthers | OmniCast Media
Hidden Brain
Hidden BrainHidden Brain, Shankar Vedantam
Radiolab
RadiolabWNYC Studios
StarTalk Radio
StarTalk RadioNeil deGrasse Tyson
Are We Doomed?
Are We Doomed?NPR Network
Science Friday
Science FridayScience Friday and WNYC Studios
Science Vs
Science VsSpotify Studios

Talking Points

Recent interactions between the hosts and their guests.

Metastatic Bladder Cancer — Rapid Case Review Issue 2
Q: When you're giving urtifitinib, how often are you having to do dose reductions to manage to keep patients on therapy?
Dose reductions are often necessary due to adverse effects, such as hand-foot syndrome.
Metastatic Bladder Cancer — Rapid Case Review Issue 2
Q: How do you manage these adverse effects associated with n-fortum-ab-vidotin, notably rash and neuropathy?
Adverse effects are typically managed with topical steroids and dose adjustments.
Prostate Cancer — Microlearning Activity 1 with Dr Rana R McKay: ESMO Congress 2025 Review
Q: So I just thought that, you know, kind of maybe this is a new sort of subset of prostate cancer?
Dr. McKay discusses the emerging data from studies like Stampede suggesting potential predictive responses to chemotherapy for patients with P10 deficiencies, highlighting the importance of addressing this subgroup in future treatments.
Prostate Cancer — Microlearning Activity 1 with Dr Rana R McKay: ESMO Congress 2025 Review
Q: Any sense about how much of a problem the glucose was?
Dr. McKay outlines that hyperglycemia is indeed a problem for patients, especially given their multiple risk factors, including ADT, aberratin, and prednisone, as they have to monitor for metabolic syndrome due to age and cardiovascular risk.
Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management
Q: What are some advocacy groups involved in research or treatment for neuroendocrine cancers?
There are numerous advocacy groups for neuroendocrine tumors, including national and local organizations that play a significant role in research and patient support.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Prostate Cancer Update

What is Prostate Cancer Update about and what kind of topics does it cover?

This show serves as a practical, clinician-focused briefing on prostate cancer research and care, featuring in-depth one-on-one interviews with leading urologic and medical oncologists. Across recent episodes, conversations center on integrating new data into patient management—covering biomarker-driven decisions, biomarker testing strategies, perioperative and metastatic approaches, trial data interpretation, and the evolving role of immunotherapies and targeted agents in both hormone-sensitive and advanced disease. A standout aspect is the emphasis on real-world case discussions and actionable takeaways for sequencing treatments, handling toxicities, and personalizing therapy through molecular profiling, often with international perspecti... more

Where can I find podcast stats for Prostate Cancer Update?

Rephonic provides a wide range of podcast stats for Prostate Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Prostate Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Prostate Cancer Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Prostate Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Prostate Cancer Update?

Rephonic provides comprehensive predictive audience data for Prostate Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Prostate Cancer Update have?

To see how many followers or subscribers Prostate Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Prostate Cancer Update?

These podcasts share a similar audience with Prostate Cancer Update:

1. Two Onc Docs
2. Gastrointestinal Cancer Update
3. Lung Cancer Update
4. Breast Cancer Update
5. Oncology Today with Dr Neil Love

How many episodes of Prostate Cancer Update are there?

Prostate Cancer Update launched 20 years ago and published 178 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Prostate Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Prostate Cancer Update?

Rephonic pulls ratings and reviews for Prostate Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Prostate Cancer Update?

Rephonic provides full transcripts for episodes of Prostate Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Prostate Cancer Update?

Recent guests on Prostate Cancer Update include:

1. Matt Milowsky
2. Nazli Dizman
3. Jacqueline Brown
4. Niraj Agarwal
5. Raina McKay
6. Matthew Galsky
7. Andrea Necchi
8. Shilpa Gupta

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days